Chuck Royce's XENE Position Overview
Chuck Royce (via Royce & Associates Lp) currently holds 65,032 shares of Xenon Pharmaceuticals Inc. (XENE) worth $3.93 M, representing 0.03% of the portfolio. First purchased in 2026-Q2, this recently established position has been held for 1 quarters.
Based on recent 13F filings, Chuck Royce has initiated a new position in XENE, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
Chuck Royce's Xenon Pharmaceuticals (XENE) Holding Value Over Time
Track share changes against reported price movement
Quarterly Xenon Pharmaceuticals (XENE) Trades by Chuck Royce
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +65,032 | New Buy | 65,032 | $60.36 |
Chuck Royce's Xenon Pharmaceuticals Investment FAQs
Chuck Royce first purchased Xenon Pharmaceuticals Inc. (XENE) in Q2 2026, acquiring 65,032 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Chuck Royce has held Xenon Pharmaceuticals Inc. (XENE) for 1 quarters since Q2 2026.
Chuck Royce's largest addition to Xenon Pharmaceuticals Inc. (XENE) was in Q2 2026, adding 65,032 shares worth $3.93 M.
According to the latest 13F filing for Q2 2026, Chuck Royce's firm, Royce & Associates Lp, owns 65,032 shares of Xenon Pharmaceuticals Inc. (XENE), valued at approximately $3.93 M.
As of the Q2 2026 filing, Xenon Pharmaceuticals Inc. (XENE) represents approximately 0.03% of Chuck Royce's publicly disclosed stock portfolio, making it one of their key holdings.
Chuck Royce's peak holding in Xenon Pharmaceuticals Inc. (XENE) was 65,032 shares, as reported at the end of Q2 2026.